Cinnarizine - Vestibular disorders
You are here : Home > Formulary Search > Cinnarizine - Vestibular disorders
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Cinnarizine
Indication :
Vestibular disorders
Group Name :
Keywords :
nausea and vomiting, vertigo, motion sickness, tinnitus, benign paroxysmal positional vertigo, BPPV, Labyrinthitis, Menieres disease
Brand Names Include :
Stugeron
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Committee Recommendations (2)
GENERIC Cinnarizine has been considered by the PCN and has been assigned a GREEN traffic light status.
NOTE - the branded product, Stugeron, was considered BLACK at the PCN in MAy 2017.
NOTE - the branded product, Stugeron, was considered BLACK at the PCN in MAy 2017.
This drug has been agreed as appropriate for initiation in Primary Care and/or continued in Primary Care following a recommendation from specialists in other health care sectors. Following consideration by the PCN, it has been assigned a GREEN traffic light status
Other Indications
Below are listed other indications that Cinnarizine is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Vestibular disorders.